Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.80
-2.42 (-8.28%)
At close: Nov 16, 2026, 4:00 PM EST
26.90
+0.10 (0.37%)
After-hours: Nov 16, 2026, 4:06 PM EST

Viking Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,4183,9774,4841,862721360
Market Cap Growth
-25.86%-11.32%140.89%158.23%100.31%-12.38%
Enterprise Value
2,7123,2633,5551,487567144
Last Close Price
29.2235.1840.2418.619.404.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.336.225.095.344.961.78
P/TBV Ratio
5.826.225.095.344.961.78

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.4300.000.000.010
Net Debt / Equity Ratio
-1.20-1.10-1.02-1.04-1.06-1.00
Quick Ratio
7.179.2132.9318.927.0923.02
Current Ratio
7.279.3333.0919.197.6123.98
Return on Equity (ROE)
-96.37%-47.34%-17.90%-34.79%-39.67%-24.65%
Return on Assets (ROA)
-47.23%-30.28%-14.77%-23.47%-23.19%-14.90%
Return on Capital Employed (ROCE)
-76.90%-61.50%-17.10%-28.90%-48.00%-27.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.18%-9.04%-2.45%-4.61%-9.55%-15.28%
Buyback Yield / Dilution
-3.55%-3.33%-15.57%-22.79%0.47%-6.34%
SEC Filings: 10-K · 10-Q